| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000260613.1 |
Cytarabine |
Breast invasive carcinoma |
0.018831884 |
Resistant |
| ENSG00000260613.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038949627 |
Resistant |
| ENSG00000260613.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.045726843 |
Resistant |
